Articles for tag: aperture, clozapine, delay, diagnosis, efficacy, impact, medication, neurobiological, psychiatry, response, treatment, treatment resistance, TRS

The Narrowing Temporal Apertures for Clozapine in Treatment-Resistant Schizophrenia

This article has not been peer reviewed. It proposes a conceptual model supported by converging observational evidence and clinical reasoning. Treatment-resistant schizophrenia affects approximately 20–30% of individuals with schizophrenia. It is characterised by inadequate response to at least two adequate trials of different antipsychotics. Clozapine remains the only antipsychotic with robust evidence of benefit in this population and is recommended as first-line treatment once treatment resistance has been identified.1 In clinical practice, clozapine initiation is frequently delayed — often by ...

Schizophrenia and TRS

Schizophrenia is a widely understood and misunderstood mental health condition. Many mental health professionals believe they ‘know’ what schizophrenia is. Ideas ‘about delusions and hallucinations’ just scratch the surface, as will be seen when ICD-11 criteria are explored. Millions of pages of journals and books have been written on this topic over the last 30 years. This article could not possibly condense all the important aspects of schizophrenia to everyone’s satisfaction. Between higher specialist training and into the first 5 ...

Placebo – simplified

This is about the nature of the placebo (and related) effects. I’m not giving a definition on this occasion. Readers can jump on the net and find whatever definitions they like. This is not an academic analysis. I’m sharing some experience and knowledge of the placebo effects. Some of these will have references to information on the net, and some will not. My mission is not primarily to ‘explain’ the placebo effect, though I may touch on some possible mechanisms. ...